[go: up one dir, main page]

FR2690340B1 - Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant. - Google Patents

Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.

Info

Publication number
FR2690340B1
FR2690340B1 FR9205050A FR9205050A FR2690340B1 FR 2690340 B1 FR2690340 B1 FR 2690340B1 FR 9205050 A FR9205050 A FR 9205050A FR 9205050 A FR9205050 A FR 9205050A FR 2690340 B1 FR2690340 B1 FR 2690340B1
Authority
FR
France
Prior art keywords
new process
resulting therefrom
stabilizing liquid
pharmaceutical compositions
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9205050A
Other languages
English (en)
Other versions
FR2690340A1 (fr
Inventor
Daniele Fredj
Francois Dietlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCR NEWMED
Original Assignee
SCR NEWMED
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCR NEWMED filed Critical SCR NEWMED
Priority to FR9205050A priority Critical patent/FR2690340B1/fr
Publication of FR2690340A1 publication Critical patent/FR2690340A1/fr
Application granted granted Critical
Publication of FR2690340B1 publication Critical patent/FR2690340B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9205050A 1992-04-24 1992-04-24 Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant. Expired - Fee Related FR2690340B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9205050A FR2690340B1 (fr) 1992-04-24 1992-04-24 Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9205050A FR2690340B1 (fr) 1992-04-24 1992-04-24 Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.

Publications (2)

Publication Number Publication Date
FR2690340A1 FR2690340A1 (fr) 1993-10-29
FR2690340B1 true FR2690340B1 (fr) 1995-02-24

Family

ID=9429214

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9205050A Expired - Fee Related FR2690340B1 (fr) 1992-04-24 1992-04-24 Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.

Country Status (1)

Country Link
FR (1) FR2690340B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
CA2153553A1 (fr) * 1994-07-13 1996-01-14 Hidekazu Suzuki Emulsion stable de lipides
DE19744811C2 (de) * 1997-10-02 1999-11-18 Medac Klinische Spezialpraep Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
AU2005201499B2 (en) * 1999-02-22 2007-03-08 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
ITMI20021725A1 (it) * 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784201A (en) * 1955-02-04 1957-10-02 Sandoz Ltd Stable solutions of relatively pure glycosides having an action on the heart
AU8533582A (en) * 1981-07-10 1984-01-12 Reckitt & Colman Products Limited Stable solutions of buprenorphine
MA20647A1 (fr) * 1985-03-25 1986-10-01 Schering Corp Compositions stables a base d'interferon-gamma
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
FI883337A7 (fi) * 1987-07-16 1989-01-17 Bristol Myers Squibb Co Doksorubisiinihydrokloridin ei-vesiliuoksia
FI883338L (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
IL83380A (en) * 1987-07-30 1991-04-15 Teva Pharma Stable aqueous cisplatin solutions
FR2624736B1 (fr) * 1987-12-16 1991-03-22 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole
US5182274A (en) * 1988-09-26 1993-01-26 Teijin Limited Stabilized aqueous preparation of active form of vitamin d3

Also Published As

Publication number Publication date
FR2690340A1 (fr) 1993-10-29

Similar Documents

Publication Publication Date Title
HU902854D0 (en) Process for the production of taxol derivatives and medical preparations containing such active agents
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
HU911295D0 (en) Process for producing pyridine derivatives and pharmaceutical preparatives containing these compounds as active substance
IL60326A (en) Pharmaceutical compositions for parenteral administration of fat-soluble active substances
HUT51617A (en) Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance
AU5441094A (en) Pharmaceutical solutions and emulsions containing taxol
IL126178A0 (en) Methods for stabilizing compositions containing taxol and pharmaceutical compositions containing taxol prepared
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
ITMO920035A0 (it) Flacone contagocce particolarmente per prodotti farmaceutici attivabili all'uso per miscelare
HU9301700D0 (en) Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance
NO914049L (no) Materialer som kan anvendes som saarbandasjer og for administrering av medikamenter
HUT64756A (en) Process for the production of quinoxaline derivatives and of pharmaceutical compositions containing them
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
TW290455B (fr)
FR2690340B1 (fr) Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
FI951961L (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
HU9301840D0 (en) Method for producing 4-hydroxi-phenyl-thio derivatives and pharmaceutical preparatives containing said compounds as active substance
HU910583D0 (en) Process for producing substituted oxazolidines and pharmaceutical preparatives containing these compounds as active substance
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
FR2682598B1 (fr) Compositions pharmaceutiques de peptides et procedes pour leur preparation.
HU904062D0 (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds as active substance
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
AU1269192A (en) Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
HUT48801A (en) Acarycides and insecticides containing as active substance derivatives of benzoil-carbamide and process for production of the active substances

Legal Events

Date Code Title Description
ST Notification of lapse
RN Application for restoration
FC Favourable decision of inpi director general on an application for restauration.
ST Notification of lapse

Effective date: 20051230